Cataya Bio
Series B in 2023
Cataya Bio (Shanghai) Co., Ltd. is a biotechnology company focused on developing synthetic biological products for various industries. Utilizing an advanced engineering biology platform, Cataya Bio engineers microbes and implements clean fermentation processes to produce high-purity products efficiently and sustainably. The company aims to facilitate the transition from petroleum-based materials to natural and sustainable raw materials, addressing critical global challenges such as environmental preservation, carbon emissions, and climate change. Through its innovative approach, Cataya Bio provides clients with effective solutions for sourcing raw materials that align with contemporary sustainability goals.
RedPine Medical
Series C in 2022
RedPine Medical, founded in 2015 and headquartered in Guangzhou, China, specializes in the manufacture of single-use medical endoscopes. The company focuses on providing advanced minimally invasive surgical devices for various applications, including urology, gynecology, ear, nose, and throat (ENT), pneumology, gastroenterology, and general surgeries. By emphasizing innovative solutions, RedPine aims to enhance detection, diagnosis, and treatment in medical settings, positioning itself as a global leader in the field of integrated minimally invasive surgical solutions.
Ruiyun Cold Chain
Seed Round in 2022
Ruiyun Cold Chain is a logistics service platform in China that specializes in cold chain transportation. Utilizing innovative domestic technology, the company offers comprehensive, digital, end-to-end cold chain integration services. Its proprietary platform, which includes Lengyunbao, a unique carrier-type online trading system, facilitates a seamless online experience for transactions, delivery, settlement, and tax collection. By fostering interaction and collaboration within a social cold chain network, Ruiyun Cold Chain effectively links industry resources with customer demand, helping businesses optimize operational efficiency and achieve significant reductions in logistics costs, typically between 10% and 15%.
Cataya Bio
Series A in 2022
Cataya Bio (Shanghai) Co., Ltd. is a biotechnology company focused on developing synthetic biological products for various industries. Utilizing an advanced engineering biology platform, Cataya Bio engineers microbes and implements clean fermentation processes to produce high-purity products efficiently and sustainably. The company aims to facilitate the transition from petroleum-based materials to natural and sustainable raw materials, addressing critical global challenges such as environmental preservation, carbon emissions, and climate change. Through its innovative approach, Cataya Bio provides clients with effective solutions for sourcing raw materials that align with contemporary sustainability goals.
Qixiangyun
Seed Round in 2022
Qixiangyun is a pioneering enterprise in China that specializes in developing an open platform for financial and taxation standard components. The company focuses on empowering independent software vendors (ISVs) by providing high-quality, standardized financial and taxation technology services tailored for terminal enterprises. Its platform features an intelligent financial and tax report accounting engine at its core, offering APIs and configurable functional modules that can seamlessly integrate with various enterprise software systems. This integration facilitates efficient digital transformation across business, finance, and taxation sectors. Additionally, Qixiangyun aims to streamline the national tax declaration process, enabling multi-enterprise and cross-regional one-click tax declaration and deduction, significantly enhancing the operational capabilities of enterprises in the digital age.
Jade Bird Display
Series A in 2022
Jade Bird Display (Shanghai) Limited is a manufacturer based in Shanghai, China, specializing in the development and production of micro-LED display chips and panels. Founded in 2015, the company focuses on research and development to create the smallest, brightest, and most efficient micro-display solutions. Its products are designed for various applications, including augmented reality (AR), virtual reality (VR), head-up displays (HUD), projectors, weapon sights, 3D printing, and microscopes. By providing ultra-compact micro-display panels, Jade Bird Display enables original equipment manufacturers to enhance user experience in AR and VR hardware, offering improved comfort, outdoor readability, and extended operating times between charges. The company also maintains an office in Hong Kong to support its operations.
TreeENT Health is a specialized healthcare provider focused on ear, nose, and throat (ENT) services, established in 2017 and headquartered in Hangzhou, China. The company operates a chain of medical centers that cater to a variety of ENT conditions, including suppurative otitis media, allergic rhinitis, chronic sinusitis, and thyroid cancer. TreeENT Health utilizes advanced medical technologies, such as minimally invasive surgical techniques, internet-enabled services, and wearable medical devices, to enhance patient care. Their offerings include diagnostic services like Danish ear hearing detection, nasal endoscopy video examinations, and nasopharyngoscopy, along with personalized chronic disease rehabilitation. The integration of online appointment scheduling through platforms like WeChat facilitates convenient access to expert consultations and treatments, ensuring a high-quality experience for patients.
Inceptio Technology
Series B in 2022
Inceptio Technology is a developer of autonomous driving heavy-duty trucks based in Shanghai, China, with additional research and development centers in Silicon Valley. Founded in 2018, the company aims to transform line-haul logistics by offering a nationwide freight network that enhances safety, efficiency, and cost-effectiveness for logistic customers. Its autonomous trucks leverage advanced artificial intelligence, new energy technology, and logistics big data to deliver innovative and reliable transportation solutions. By focusing on the integration of these technologies, Inceptio Technology is positioned to provide significant improvements in the logistics sector.
UWinTech is a provider of comprehensive IT operations and maintenance solutions based in Shenzhen, China. Founded in 2015, the company offers a range of services including EasyCMDB for configuration management, Easydevops for DevOps practices, Easyobserve for monitoring, EasyMAbuilder for automation, and Easyautoops for operational efficiency. UWinTech's services are designed to help enterprises reduce efforts and maximize productivity by covering continuous delivery, continuous deployment, operation automation, and application monitoring.
Ruiyun Cold Chain
Seed Round in 2021
Ruiyun Cold Chain is a logistics service platform in China that specializes in cold chain transportation. Utilizing innovative domestic technology, the company offers comprehensive, digital, end-to-end cold chain integration services. Its proprietary platform, which includes Lengyunbao, a unique carrier-type online trading system, facilitates a seamless online experience for transactions, delivery, settlement, and tax collection. By fostering interaction and collaboration within a social cold chain network, Ruiyun Cold Chain effectively links industry resources with customer demand, helping businesses optimize operational efficiency and achieve significant reductions in logistics costs, typically between 10% and 15%.
Inceptio Technology
Series B in 2021
Inceptio Technology is a developer of autonomous driving heavy-duty trucks based in Shanghai, China, with additional research and development centers in Silicon Valley. Founded in 2018, the company aims to transform line-haul logistics by offering a nationwide freight network that enhances safety, efficiency, and cost-effectiveness for logistic customers. Its autonomous trucks leverage advanced artificial intelligence, new energy technology, and logistics big data to deliver innovative and reliable transportation solutions. By focusing on the integration of these technologies, Inceptio Technology is positioned to provide significant improvements in the logistics sector.
Blueglass Yogurt
Series B in 2021
Blueglass Yogurt is a food and beverage brand based in China that specializes in a diverse range of yogurt-based products. The company offers an extensive selection, including signature fancy yogurt, fruit yogurt, yogurt salads, cakes, pastries, drinks, and ice cream. By owning and operating its stores, Blueglass Yogurt ensures that customers have access to freshly made yogurt, enhancing the overall consumer experience. The brand aims to cater to the growing demand for fresh and innovative yogurt products among domestic consumers.
Ruiyun Cold Chain
Angel Round in 2021
Ruiyun Cold Chain is a logistics service platform in China that specializes in cold chain transportation. Utilizing innovative domestic technology, the company offers comprehensive, digital, end-to-end cold chain integration services. Its proprietary platform, which includes Lengyunbao, a unique carrier-type online trading system, facilitates a seamless online experience for transactions, delivery, settlement, and tax collection. By fostering interaction and collaboration within a social cold chain network, Ruiyun Cold Chain effectively links industry resources with customer demand, helping businesses optimize operational efficiency and achieve significant reductions in logistics costs, typically between 10% and 15%.
Know Yourself
Series A in 2021
Know Yourself is a prominent psychology education platform based in China, dedicated to enhancing mental health and well-being among urban youth. With a substantial following of over 3 million on social media, the platform offers a variety of psychoeducational resources, including articles, lectures, and courses. It serves as the largest online community for psychological education in the country, promoting mental health awareness through self-help tools, a supportive community, and a range of psychology-related services. These services cover areas such as self-exploration, developmental psychology, and clinical psychology, aiming to provide valuable insights and support for individuals seeking to understand and improve their mental health.
B-One Ortho Corp. is a manufacturer of orthopedic healthcare solutions, specializing in artificial joints that facilitate joint replacement surgeries. Founded in 2015 and headquartered in Cedar Knolls, New Jersey, the company also maintains offices in Shanghai and Suzhou, China. Its notable products include the B-One total hip system, which features advanced coating technology and instrumentation, as well as the Juveno bone-conserving femoral prosthesis and primary acetabular systems. These innovations aim to enhance the effectiveness of hip and knee arthroplasty, ultimately helping patients regain their mobility and improve their quality of life.
Founded in 2016, Pony.ai develops artificial intelligence software for autonomous mobility deployment, focusing on manufacturing automated vehicles and offering public-facing Robotaxi services. The company operates fully driverless robotaxis through the PonyPilot mobile app in major Chinese cities.
RedPine Medical
Series A in 2020
RedPine Medical, founded in 2015 and headquartered in Guangzhou, China, specializes in the manufacture of single-use medical endoscopes. The company focuses on providing advanced minimally invasive surgical devices for various applications, including urology, gynecology, ear, nose, and throat (ENT), pneumology, gastroenterology, and general surgeries. By emphasizing innovative solutions, RedPine aims to enhance detection, diagnosis, and treatment in medical settings, positioning itself as a global leader in the field of integrated minimally invasive surgical solutions.
Pony.ai
Venture Round in 2020
Founded in 2016, Pony.ai develops artificial intelligence software for autonomous mobility deployment, focusing on manufacturing automated vehicles and offering public-facing Robotaxi services. The company operates fully driverless robotaxis through the PonyPilot mobile app in major Chinese cities.
InDeco China
Series C in 2020
InDeco China, founded in 2016 and headquartered in Beijing, is a commercial office decoration solution provider that modernizes the traditional decoration industry. The company offers comprehensive services, including space design, material selection, product sourcing, and construction process management, utilizing an integrated approach that leverages Internet-based thinking. InDeco aims to streamline the decoration process, enabling clients to efficiently transform their spaces while ensuring quality and consistency throughout each project.
B-One
Venture Round in 2020
B-One Ortho Corp. is a manufacturer of orthopedic healthcare solutions, specializing in artificial joints that facilitate joint replacement surgeries. Founded in 2015 and headquartered in Cedar Knolls, New Jersey, the company also maintains offices in Shanghai and Suzhou, China. Its notable products include the B-One total hip system, which features advanced coating technology and instrumentation, as well as the Juveno bone-conserving femoral prosthesis and primary acetabular systems. These innovations aim to enhance the effectiveness of hip and knee arthroplasty, ultimately helping patients regain their mobility and improve their quality of life.
Founded in 2014, Medbanks specializes in healthcare data processing services. It develops an oncology database by collecting and analyzing clinical information from hospitals.
Hedone is a company based in Shanghai, China, operating an e-commerce platform specializing in beauty and makeup products. Founded in 2014, Hedone caters primarily to Chinese millennials, offering a range of fashion and beauty items designed to embrace individuality.
TreeENT Health is a specialized healthcare provider focused on ear, nose, and throat (ENT) services, established in 2017 and headquartered in Hangzhou, China. The company operates a chain of medical centers that cater to a variety of ENT conditions, including suppurative otitis media, allergic rhinitis, chronic sinusitis, and thyroid cancer. TreeENT Health utilizes advanced medical technologies, such as minimally invasive surgical techniques, internet-enabled services, and wearable medical devices, to enhance patient care. Their offerings include diagnostic services like Danish ear hearing detection, nasal endoscopy video examinations, and nasopharyngoscopy, along with personalized chronic disease rehabilitation. The integration of online appointment scheduling through platforms like WeChat facilitates convenient access to expert consultations and treatments, ensuring a high-quality experience for patients.
Founded in 2014, Medbanks specializes in healthcare data processing services. It develops an oncology database by collecting and analyzing clinical information from hospitals.
B-One Ortho Corp. is a manufacturer of orthopedic healthcare solutions, specializing in artificial joints that facilitate joint replacement surgeries. Founded in 2015 and headquartered in Cedar Knolls, New Jersey, the company also maintains offices in Shanghai and Suzhou, China. Its notable products include the B-One total hip system, which features advanced coating technology and instrumentation, as well as the Juveno bone-conserving femoral prosthesis and primary acetabular systems. These innovations aim to enhance the effectiveness of hip and knee arthroplasty, ultimately helping patients regain their mobility and improve their quality of life.
UWinTech is a provider of comprehensive IT operations and maintenance solutions based in Shenzhen, China. Founded in 2015, the company offers a range of services including EasyCMDB for configuration management, Easydevops for DevOps practices, Easyobserve for monitoring, EasyMAbuilder for automation, and Easyautoops for operational efficiency. UWinTech's services are designed to help enterprises reduce efforts and maximize productivity by covering continuous delivery, continuous deployment, operation automation, and application monitoring.
Founded in 2016, Pony.ai develops artificial intelligence software for autonomous mobility deployment, focusing on manufacturing automated vehicles and offering public-facing Robotaxi services. The company operates fully driverless robotaxis through the PonyPilot mobile app in major Chinese cities.
Kongming Inc. is a Beijing-based company established in 2010 that specializes in social media technology and marketing solutions. It offers a range of products and services, including social monitoring tools, customer relationship management (CRM) systems, social networking advertising, and data analysis services. By leveraging these capabilities, Kongming aims to enhance client interactions and optimize marketing strategies within the social media landscape.
Hua Medicine
Series D in 2018
Hua Medicine is a clinical-stage drug development company in China focused on therapies for diabetes and CNS disorders. It develops Dorzagliatin (also known as HMS5552), an oral, first-in-class glucokinase activator for type 2 diabetes, and has advanced Dorzagliatin into NDA-enabling work and Phase III trials in China, including studies in drug-naive and metformin-treated patients. The company is pursuing Dorzagliatin in combination with metformin and in combination with DPP-4 inhibitors, SGLT-2 inhibitors, and insulin in various development stages. In addition, Hua Medicine is developing mGluR5 candidates for Parkinson's disease and related levodopa-induced dyskinesia. The company was founded in 2011 and is headquartered in Shanghai, China.
B-One
Venture Round in 2018
B-One Ortho Corp. is a manufacturer of orthopedic healthcare solutions, specializing in artificial joints that facilitate joint replacement surgeries. Founded in 2015 and headquartered in Cedar Knolls, New Jersey, the company also maintains offices in Shanghai and Suzhou, China. Its notable products include the B-One total hip system, which features advanced coating technology and instrumentation, as well as the Juveno bone-conserving femoral prosthesis and primary acetabular systems. These innovations aim to enhance the effectiveness of hip and knee arthroplasty, ultimately helping patients regain their mobility and improve their quality of life.
UWinTech
Venture Round in 2018
UWinTech is a provider of comprehensive IT operations and maintenance solutions based in Shenzhen, China. Founded in 2015, the company offers a range of services including EasyCMDB for configuration management, Easydevops for DevOps practices, Easyobserve for monitoring, EasyMAbuilder for automation, and Easyautoops for operational efficiency. UWinTech's services are designed to help enterprises reduce efforts and maximize productivity by covering continuous delivery, continuous deployment, operation automation, and application monitoring.
Cytek Biosciences
Series B in 2017
Cytek Biosciences, Inc. is a manufacturer and supplier of flow cytometry tools and equipment specifically designed for cancer and cell biology research. The company offers advanced flow cytometers, including the Cytek Aurora and Cytek Northern Lights, as well as the DxP Athena system, which utilizes proprietary technology to enhance the detection of dim populations in a multicolor format. In addition, Cytek provides the QbSure quality control program to ensure the optimal performance of its cytometers and a range of cFluor reagents tailored for use in multicolor applications. Established in 1990 and headquartered in Fremont, California, Cytek has expanded its presence internationally with locations in Bethesda, Maryland; Amsterdam, the Netherlands; Tokyo, Japan; and Shanghai, China. The company was previously known as Cytoville, Inc. before rebranding in August 2015.
Hua Medicine
Series C in 2016
Hua Medicine is a clinical-stage drug development company in China focused on therapies for diabetes and CNS disorders. It develops Dorzagliatin (also known as HMS5552), an oral, first-in-class glucokinase activator for type 2 diabetes, and has advanced Dorzagliatin into NDA-enabling work and Phase III trials in China, including studies in drug-naive and metformin-treated patients. The company is pursuing Dorzagliatin in combination with metformin and in combination with DPP-4 inhibitors, SGLT-2 inhibitors, and insulin in various development stages. In addition, Hua Medicine is developing mGluR5 candidates for Parkinson's disease and related levodopa-induced dyskinesia. The company was founded in 2011 and is headquartered in Shanghai, China.
Cytek Biosciences
Venture Round in 2016
Cytek Biosciences, Inc. is a manufacturer and supplier of flow cytometry tools and equipment specifically designed for cancer and cell biology research. The company offers advanced flow cytometers, including the Cytek Aurora and Cytek Northern Lights, as well as the DxP Athena system, which utilizes proprietary technology to enhance the detection of dim populations in a multicolor format. In addition, Cytek provides the QbSure quality control program to ensure the optimal performance of its cytometers and a range of cFluor reagents tailored for use in multicolor applications. Established in 1990 and headquartered in Fremont, California, Cytek has expanded its presence internationally with locations in Bethesda, Maryland; Amsterdam, the Netherlands; Tokyo, Japan; and Shanghai, China. The company was previously known as Cytoville, Inc. before rebranding in August 2015.
QuanCheng
Series B in 2016
Founded in November 2013 and headquartered in Shanghai, QuanCheng is a SaaS startup that focuses on corporate expense management and vendor management. The company offers a centralized purchasing management platform that provides tools and services for managing expenses related to business dining and travel. With a presence in 50 tier-one and tier-two cities across China, including major urban centers such as Beijing, Guangzhou, Shenzhen, and Wuhan, QuanCheng aims to optimize operational efficiency for businesses through its specialized software solutions.
Fishtrip
Venture Round in 2015
Fishtrip is an online marketplace headquartered in Beijing, China, catering to Chinese holiday-makers looking for unique overseas accommodations. The platform focuses on providing distinctive lodging options that enhance travel experiences, allowing users to discover and book unconventional properties around the world. Established as a subsidiary of Tujia Online Information Technology, Fishtrip leverages the growing trend of experiential travel among Chinese tourists, positioning itself as a key player in the international travel market. Through its innovative approach, Fishtrip aims to meet the evolving preferences of its customers, offering tailored solutions for memorable travel experiences.
Founded in 2014, Medbanks specializes in healthcare data processing services. It develops an oncology database by collecting and analyzing clinical information from hospitals.
Gshopper operates a cross-border e-commerce platform, offering a curated selection of electronics, cosmetics, health, kids, and outdoor products. Headquartered in Singapore, the company uses advanced data analytics and AI to identify trending global products, providing consumers worldwide with convenient access to high-quality goods at competitive prices.
Innovent Biologics
Series C in 2015
Innovent Biologics is a China-based biopharmaceutical company that discovers, develops, manufactures, and commercializes monoclonal antibodies. It operates a platform for antibody therapeutics across oncology, ophthalmology, immunology, and metabolic diseases, with Tyvyt (sintilimab) as its core asset, a PD-1 inhibitor used in first-line and other cancer indications. The company develops a broad pipeline including biosimilars and novel antibodies and provides distribution, consulting, and R&D services. It maintains strategic collaborations with global partners, including a co-development arrangement with MD Anderson Cancer Center and an alliance with Eli Lilly for TYVYT, and has more than 30 collaborations with major pharmaceutical companies. Innovent is listed on the Hong Kong Exchange and maintains manufacturing and development capabilities in China with a growing portfolio of oncology and non-oncology products marketed domestically and internationally.
Zaker is a company based in Guangzhou, China, that develops a mobile internet reading platform aimed at personalized news consumption. Its flagship application aggregates news content from various professional media sources, offering users an interactive experience tailored to their reading preferences. The app not only allows users to engage with diverse news topics but also facilitates discussions and content sharing across multiple social media platforms. Additionally, Zaker provides services related to content application and management across different industries, leveraging data governance and development to foster an intelligent content ecosystem. This approach is designed to enhance the efficiency and capabilities of content businesses, enabling them to achieve smarter upgrades and improved interaction with their audiences.
Eyebright
Venture Round in 2014
Eyebright Medical Technology (Beijing) Co Ltd is dedicated to the research, development, production, and sales of ophthalmic medical devices aimed at improving eye health and vision. The company offers a diverse range of products, including intraocular lenses, IOL delivery systems, surgical instruments, optometric lenses, and eye drops, all designed to address various ophthalmic conditions such as cataracts, glaucoma, and refractive errors. In addition to its product offerings, Eyebright provides related services to support the effective use of its medical devices, contributing to advancements in eye care and treatment.
Kmsocial is a provider of social media management tools aimed at enhancing promotional efficiency across various social media platforms, particularly in China. The company's flagship offering is the Kongming Social Management Platform, which encompasses a range of services including Weibo operation, social media monitoring, customer relationship management (CRM), social network advertising, and data analysis. By leveraging these services, Kmsocial enables clients to effectively promote their products and engage with their audience through targeted social media strategies.
Bang Er Orthopedic
Series A in 2014
Zhejiang Bang Er Medical Investment Management Co., Ltd. is a prominent operator of hospitals specializing in orthopedic care and rehabilitation services, established in 2012 in Zhejiang Province, China. The company focuses on the diagnosis and treatment of various orthopedic conditions, including trauma-related injuries, hand and foot surgery, spine surgery, and joint surgery. By offering a comprehensive range of services, Bang Er aims to provide patients with the necessary care and treatment options for their orthopedic ailments, positioning itself as a key player in the healthcare sector of the Yangtze River Delta.
YOKA.com is a Chinese fashion website that caters to high-income earners seeking premium brands and an elevated quality of life. It operates as a comprehensive sub-brand under Trends Media Group, which publishes 17 magazines including Cosmopolitan, Esquire, Harper's Bazaar, and custom-made titles like Audi and Toyota. The company adheres to the principle "Think Global, Act Local," collaborating with renowned media groups through copyright agreements and joint ventures. YOKA.com provides a diverse range of fashion information, focusing on beauty, makeup, and other fashion-related products and services.
Innovent Biologics
Series B in 2012
Innovent Biologics is a China-based biopharmaceutical company that discovers, develops, manufactures, and commercializes monoclonal antibodies. It operates a platform for antibody therapeutics across oncology, ophthalmology, immunology, and metabolic diseases, with Tyvyt (sintilimab) as its core asset, a PD-1 inhibitor used in first-line and other cancer indications. The company develops a broad pipeline including biosimilars and novel antibodies and provides distribution, consulting, and R&D services. It maintains strategic collaborations with global partners, including a co-development arrangement with MD Anderson Cancer Center and an alliance with Eli Lilly for TYVYT, and has more than 30 collaborations with major pharmaceutical companies. Innovent is listed on the Hong Kong Exchange and maintains manufacturing and development capabilities in China with a growing portfolio of oncology and non-oncology products marketed domestically and internationally.
Lumi Shanghai
Series A in 2012
Shanghai Lumi Information Technology Limited Company (Lumi胶原蛋白/禄美) is dedicated to research and development of beauty and health series products.
Lumi is mainly engaged in the R&D, brand building, and market promotion of brand cosmetology and health products, and it is a matchless brand of collagen protein in the domestic industry. Lumi owns its market by new marketing modes, which now possesses a self-constructed call center with over a 100people and plans to extend the number to more than 200 people within the year.
Yoyi Digital
Series C in 2012
Yoyi Digital, established in 2007 and headquartered in Beijing, China, specializes in providing online advertising and marketing solutions tailored for advertisers and media publishers. The company leads the programmatic buying industry in China, focusing on data-driven strategies that facilitate the transition from media buying to audience buying. Yoyi Digital offers a comprehensive suite of services, including targeted advertisement delivery, customer relationship management, and innovative media planning. Its proprietary platforms, such as Databank, enable advertisers to collect and analyze first-party data effectively. Yoyi has pioneered cross-screen programmatic buying, integrating digital media strategies across devices including PCs, mobile, video, and OTT. The company serves over 1,000 global and local brands, utilizing advanced advertising technologies to enhance user experience and advertising effectiveness. Yoyi Digital has received multiple accolades, including recognition as a Red Herring 100 Global Winner and accolades at the Ad Stars Festival. With branches in Shanghai and Guangzhou, the organization continues to drive the evolution of digital marketing in China.
Pod Inns (布丁酒店) is a provider of contemporary and convenient accommodations in the Chinese hotel industry. It is focused on high-end customers. Pod Inns has over 300 hotels in more than 40 cities such as Beijing, Shanghai, Tianjin, Wuhan, and Xian with 8 million registered members.
Since its establishment in China, Pod Inns has delivered accepted services and aims to reach higher through product innovation, professional management and service, and efficient cost control.
Romax Technology
Venture Round in 2012
Romax Technology Limited is an engineering firm based in Nottingham, United Kingdom, specializing in software, analysis, and services for various industries, including automotive, wind energy, aerospace, and rail. Founded in 1989, the company provides a range of solutions such as RomaxDESIGNER for modeling and analyzing transmissions and drivelines, CAD FUSION for detailed simulations, and Dynamic FUSION for streamlined design processes. Romax Technology also offers RomaxWIND for driveline dynamics and multi-physics simulations, as well as InSight Fleet Monitor for design and optimization. Additionally, the company delivers engineering services, training, consulting, and testing to enhance drivetrain design, simulation, and monitoring applications. With a global presence that includes offices in the United States, China, Japan, Korea, India, and Europe, Romax Technology serves as a key player in the development of energy-efficient drive and power generation systems.
Hua Medicine
Series A in 2011
Hua Medicine is a clinical-stage drug development company in China focused on therapies for diabetes and CNS disorders. It develops Dorzagliatin (also known as HMS5552), an oral, first-in-class glucokinase activator for type 2 diabetes, and has advanced Dorzagliatin into NDA-enabling work and Phase III trials in China, including studies in drug-naive and metformin-treated patients. The company is pursuing Dorzagliatin in combination with metformin and in combination with DPP-4 inhibitors, SGLT-2 inhibitors, and insulin in various development stages. In addition, Hua Medicine is developing mGluR5 candidates for Parkinson's disease and related levodopa-induced dyskinesia. The company was founded in 2011 and is headquartered in Shanghai, China.
Betterlife Medical
Venture Round in 2011
Betterlife Medical is a high-tech medical device company focused on serving the Chinese market. The company specializes in developing innovative medical devices, including digital programmable hearing aids and various monitoring devices. These products aim to enhance the ability of physicians to diagnose and treat their patients effectively, contributing to improved healthcare outcomes. By leveraging advanced technology, Betterlife Medical addresses critical healthcare needs and supports the evolving landscape of medical treatment in China.
Coinage
Venture Round in 2011
Financial training service provider in China.
Kongming
Venture Round in 2011
Kongming Inc. is a Beijing-based company established in 2010 that specializes in social media technology and marketing solutions. It offers a range of products and services, including social monitoring tools, customer relationship management (CRM) systems, social networking advertising, and data analysis services. By leveraging these capabilities, Kongming aims to enhance client interactions and optimize marketing strategies within the social media landscape.
Hua Medicine
Venture Round in 2010
Hua Medicine is a clinical-stage drug development company in China focused on therapies for diabetes and CNS disorders. It develops Dorzagliatin (also known as HMS5552), an oral, first-in-class glucokinase activator for type 2 diabetes, and has advanced Dorzagliatin into NDA-enabling work and Phase III trials in China, including studies in drug-naive and metformin-treated patients. The company is pursuing Dorzagliatin in combination with metformin and in combination with DPP-4 inhibitors, SGLT-2 inhibitors, and insulin in various development stages. In addition, Hua Medicine is developing mGluR5 candidates for Parkinson's disease and related levodopa-induced dyskinesia. The company was founded in 2011 and is headquartered in Shanghai, China.
BioRegen
Venture Round in 2010
Founded in Changzhou, Jiangsu Province, China in 2008, BioRegen specializes in the development of biomedical materials, regenerative medicines, and drug delivery systems. The company focuses on hyaluronic acid-based products enriched with extracellular matrix materials like hyaluronan, glycosaminoglycans, and collagen. Their innovations aim to enhance healing and rejuvenation for patients across various surgical disciplines, including ENT, orthopedics, and general surgeries.
ChinaPNR
Venture Round in 2010
ChinaPNR Mobile Payments Solutions Pvt. Ltd., founded in 2006 and based in Shanghai, is a financial payment company specializing in third-party payment services. It provides a comprehensive range of online, mobile, and offline payment and settlement solutions aimed at both B2B and B2C markets. The company focuses on enhancing its core competitiveness through advanced technology and operational excellence, ensuring the security of customer data while creating value for clients. Notable products include "Money Manager," which supports e-commerce within traditional distribution, and Tiantianying, a one-stop financial platform that has attracted nearly 2 million registered users. ChinaPNR has established strategic partnerships with numerous banks and fund firms, facilitating seamless investment in fund products. The company has demonstrated significant growth, with annual transaction volumes surpassing 1.8 trillion, ranking it among the leaders in the third-party payment industry.
ChinaPNR
Venture Round in 2010
ChinaPNR Mobile Payments Solutions Pvt. Ltd., founded in 2006 and based in Shanghai, is a financial payment company specializing in third-party payment services. It provides a comprehensive range of online, mobile, and offline payment and settlement solutions aimed at both B2B and B2C markets. The company focuses on enhancing its core competitiveness through advanced technology and operational excellence, ensuring the security of customer data while creating value for clients. Notable products include "Money Manager," which supports e-commerce within traditional distribution, and Tiantianying, a one-stop financial platform that has attracted nearly 2 million registered users. ChinaPNR has established strategic partnerships with numerous banks and fund firms, facilitating seamless investment in fund products. The company has demonstrated significant growth, with annual transaction volumes surpassing 1.8 trillion, ranking it among the leaders in the third-party payment industry.
Mineloader Software
Venture Round in 2008
Mineloader Software (上海皿鎏软件) is a third party game developer based in China. It has developed more than 10 AAA games.
With a development team of over 200 people, clients of Mineloader includes game publishers such as CAPCOM, EA, NAMCO BANDAI, SQUARE ENIX, and TAKE TWO. Its game development team consists of experienced and top level professionals worldwide.
Mineloader Software was founded in 2003 and is located in Yangpu District of Shanghai, China.
Wisers Information
Venture Round in 2008
Wisers Information Limited, established in 1998 and headquartered in Wan Chai, Hong Kong, is a leading provider of Chinese media and business intelligence solutions. The company specializes in a wide range of services, including enterprise search, media and social intelligence, and financial and risk intelligence, catering to various sectors such as education, luxury and retail, government, and information technology. Wisers aggregates data from diverse media sources, including online platforms, social media, print, and broadcast media, enabling clients to access crucial insights for decision-making. Its offerings include WiseSearch, a database tailored for Chinese markets, WiseSocial for social listening, and solutions for risk management and competitive analysis. The company serves a diverse clientele, including local blue-chip firms, Fortune 500 companies, international banks, and governmental organizations across China and the Hong Kong Special Administrative Region, supporting their need for actionable intelligence and market understanding. Additionally, Wisers maintains a presence in major cities such as Beijing, Guangzhou, and Shanghai, enhancing its ability to serve clients effectively.
Crystal CG
Venture Round in 2008
Crystal CG Ltd. is a Beijing-based company established in 1995 that specializes in providing visual creative solutions through advanced 3D visualization and digital graphics technology. The company offers a comprehensive range of services, including architectural visualization, commercial property promotion, exhibition design, and digital city platforms. Additionally, Crystal CG is involved in the production of film and television special effects, animation, and integrated audio-video applications. Its expertise extends to hardware and software integration for various sectors, enabling effective communication, entertainment, and customized applications. With operations in major cities globally, including Shanghai, Los Angeles, and Tokyo, Crystal CG aims to be a leading provider of integrated digital and visual services, catering to diverse client needs in publicity, presentation, and event management.
Picsolve
Venture Round in 2008
Picsolve specializes in image capture solutions for the leisure and entertainment industry, boasting over 20 years of experience in the field. With a global presence in the UK, UAE, USA, and Hong Kong, the company offers comprehensive services that ensure efficient operations across various locations. Picsolve's approach combines retail expertise with advanced technology and innovative strategies, all aimed at enhancing guest experiences. By focusing on delivering high-quality image capture, the company plays a significant role in enriching visitor engagement in theme parks, attractions, and other entertainment venues.
Optegra
Venture Round in 2008
Optegra is a specialist provider of ophthalmic services operating a network of eye-care hospitals and clinics in the United Kingdom, with an international footprint comprising facilities in China, Germany, the Czech Republic and Poland. The company offers cataract surgery, laser eye surgery, lens replacement, medical eye treatments, vitrectomy, and cosmetic eyelid procedures, and treats conditions such as age-related macular degeneration, glaucoma and other eye conditions. By combining surgical and medical ophthalmic services across its network, Optegra aims to provide accessible, comprehensive eye care.
HuaXun Microelectronics
Series A in 2007
HuaXun Microelectronics Inc., established in 2004 and based in Xi’an, China, specializes in the research and development of satellite positioning chipsets, OEM modules, and application systems. The company designs and manufactures a range of products, including GPS RF chips, digital baseband chips, embedded software, handheld GPS navigators, and various GPS application systems. Founded by five individuals with PhD degrees and extensive experience in the American information technology sector, HuaXun focuses on technologies compatible with GPS, Galileo, and Beidou positioning systems, contributing to advancements in microelectronics and communications.
WuXi AppTec
Series C in 2007
WuXi AppTec is a global provider of research and manufacturing services for the pharmaceutical, biotech, and medical device industries. The company supports the full development spectrum—from discovery and early research through development, testing, and manufacturing of small molecule drugs and cell and gene therapies. Its capabilities include laboratory services such as synthetic, medicinal, and analytical chemistry; bioanalytical testing; toxicology; drug metabolism and pharmacokinetics; and testing for medical devices safety. It also offers clinical research and management services for phase I–IV trials, embedded outsourcing, and clinical informatics, along with contract manufacturing and development (CMO/CDMO) services and administrative support. WuXi AppTec operates globally with laboratories and operations in China, the United States, Europe, and other regions, serving pharmaceutical, biotech, and medical device customers. The company emphasizes collaboration and an integrated platform to accelerate drug discovery, development, and manufacturing, helping partners bring therapies to patients efficiently.
Novamed
Venture Round in 2007
Novamed is a company focused on addressing significant unmet medical needs in China by developing and distributing innovative therapies. It engages in the registration, manufacturing, and sale of pharmaceutical products, primarily for non-investment purposes. In addition to its distribution efforts, Novamed provides comprehensive services that include clinical development, drug registration, importation, and commercialization for products that are in late-stage development. By facilitating these processes, Novamed supports the introduction of new therapies to the Chinese market, aiming to improve healthcare outcomes for patients.
WuXi AppTec
Series B in 2006
WuXi AppTec is a global provider of research and manufacturing services for the pharmaceutical, biotech, and medical device industries. The company supports the full development spectrum—from discovery and early research through development, testing, and manufacturing of small molecule drugs and cell and gene therapies. Its capabilities include laboratory services such as synthetic, medicinal, and analytical chemistry; bioanalytical testing; toxicology; drug metabolism and pharmacokinetics; and testing for medical devices safety. It also offers clinical research and management services for phase I–IV trials, embedded outsourcing, and clinical informatics, along with contract manufacturing and development (CMO/CDMO) services and administrative support. WuXi AppTec operates globally with laboratories and operations in China, the United States, Europe, and other regions, serving pharmaceutical, biotech, and medical device customers. The company emphasizes collaboration and an integrated platform to accelerate drug discovery, development, and manufacturing, helping partners bring therapies to patients efficiently.
WuXi AppTec
Series A in 2005
WuXi AppTec is a global provider of research and manufacturing services for the pharmaceutical, biotech, and medical device industries. The company supports the full development spectrum—from discovery and early research through development, testing, and manufacturing of small molecule drugs and cell and gene therapies. Its capabilities include laboratory services such as synthetic, medicinal, and analytical chemistry; bioanalytical testing; toxicology; drug metabolism and pharmacokinetics; and testing for medical devices safety. It also offers clinical research and management services for phase I–IV trials, embedded outsourcing, and clinical informatics, along with contract manufacturing and development (CMO/CDMO) services and administrative support. WuXi AppTec operates globally with laboratories and operations in China, the United States, Europe, and other regions, serving pharmaceutical, biotech, and medical device customers. The company emphasizes collaboration and an integrated platform to accelerate drug discovery, development, and manufacturing, helping partners bring therapies to patients efficiently.
Alibaba Group
Series D in 2004
Alibaba Group facilitates online marketplaces connecting buyers and sellers globally. It specializes in retail and wholesale transactions via platforms like Taobao and Tmall. Additionally, it offers cloud computing services and digital media entertainment.
Alibaba Group
Private Equity Round in 2000
Alibaba Group facilitates online marketplaces connecting buyers and sellers globally. It specializes in retail and wholesale transactions via platforms like Taobao and Tmall. Additionally, it offers cloud computing services and digital media entertainment.
Alibaba Group
Angel Round in 1999
Alibaba Group facilitates online marketplaces connecting buyers and sellers globally. It specializes in retail and wholesale transactions via platforms like Taobao and Tmall. Additionally, it offers cloud computing services and digital media entertainment.
AsiaInfo Technologies
Venture Round in 1997
AsiaInfo Technologies is a telecommunications software and IT services provider that develops BSS and OSS solutions and related data analytics for telecommunications operators worldwide. Its Veris product family includes Veris Billing, Veris CRM, Veris BI, Veris RTI, Veris Open Operational Platform, Veris Cloud Core, and Veris Agile Core for cloud and on-premises deployments. The company offers business consulting, IT planning, systems integration, and training, with services spanning deployment, integration, and managed support. Headquartered in Beijing, with offices in Singapore and the United Kingdom, AsiaInfo was founded in 1993 and focuses on project-based software development contracts, delivering end-to-end software products and professional services to telecom and related industries, including IoT and digital services.